Cure My Disease

Don't miss your cure!

 Log in / Sign up

A safety net after jail: can checkups keep opioid treatment on track?

NCT ID NCT04365920

Disease control Sponsor: Chestnut Health Systems Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether regular checkups after release from jail can help people with opioid use disorder stay in treatment. Researchers will compare standard re-entry care with two versions of a Recovery Management Checkups program, one with monthly meetings for three months and another that adapts the schedule to each person's needs. About 455 men and women leaving six Illinois jails will take part, and researchers will track their treatment for up to two years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Recovery Management Checkups, a program of regular face-to-face meetings to assess treatment needs and encourage re-engagement in opioid use disorder treatment
What this could lead to
If it works, this could point toward a practical way to keep people with opioid use disorder in treatment after jail, reducing relapse and improving long-term outcomes.
What could go wrong
The trial is still testing the approach, and results may not apply to all jails or communities. The program depends on participants attending checkups, which may not happen for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

455 people

The number who actually took part.

Started

Aug 2021

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * meets DSM-5 opioid use disorder criteria in the past year * reports heroin or other opioid use in the 90 days prior to entering jail * is released from 1 of the participating jails. Exclusion Criteria: * is under age 18 * has cognitive impairment that precludes ability to give informed consent * resides outside the service area.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid-use disorder

Contacts and locations

Locations

  • Chestnut Health Systems-Lighthouse Institute

    Chicago, Illinois, 60610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.